Ad is loading...
ANNX
Price
$5.17
Change
+$0.01 (+0.19%)
Updated
Nov 22, 03:15 PM (EDT)
118 days until earnings call
INZY
Price
$2.80
Change
+$0.11 (+4.09%)
Updated
Nov 22, 03:18 PM (EDT)
118 days until earnings call
Ad is loading...

ANNX vs INZY

Header iconANNX vs INZY Comparison
Open Charts ANNX vs INZYBanner chart's image
Annexon
Price$5.17
Change+$0.01 (+0.19%)
Volume$500
CapitalizationN/A
Inozyme Pharma
Price$2.80
Change+$0.11 (+4.09%)
Volume$100
CapitalizationN/A
ANNX vs INZY Comparison Chart
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ANNX vs. INZY commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Sell and INZY is a Buy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (ANNX: $5.17 vs. INZY: $2.69)
Brand notoriety: ANNX and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 150% vs. INZY: 138%
Market capitalization -- ANNX: $551.09M vs. INZY: $179.23M
ANNX [@Biotechnology] is valued at $551.09M. INZY’s [@Biotechnology] market capitalization is $179.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileINZY’s FA Score has 1 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • INZY’s FA Score: 1 green, 4 red.
According to our system of comparison, ANNX is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 4 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • ANNX’s TA Score: 4 bullish, 6 bearish.
  • INZY’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, ANNX is a better buy in the short-term than INZY.

Price Growth

ANNX (@Biotechnology) experienced а -18.33% price change this week, while INZY (@Biotechnology) price change was -21.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.01%.

Reported Earning Dates

ANNX is expected to report earnings on Mar 20, 2025.

INZY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANNX($551M) has a higher market cap than INZY($179M). ANNX YTD gains are higher at: 13.877 vs. INZY (-36.854). INZY has higher annual earnings (EBITDA): -90.3M vs. ANNX (-129.45M). ANNX has more cash in the bank: 340M vs. INZY (132M). ANNX has less debt than INZY: ANNX (29.6M) vs INZY (46.8M). ANNX (0) and INZY (0) have equivalent revenues.
ANNXINZYANNX / INZY
Capitalization551M179M308%
EBITDA-129.45M-90.3M143%
Gain YTD13.877-36.854-38%
P/E RatioN/AN/A-
Revenue00-
Total Cash340M132M258%
Total Debt29.6M46.8M63%
TECHNICAL ANALYSIS
Technical Analysis
ANNXINZY
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
85%
Bullish Trend 19 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSFHX20.910.13
+0.63%
MFS Total Return R3
MDDRX10.54N/A
N/A
MassMutual Diversified Value R4
MXYKX6.63N/A
N/A
Empower T. Rowe Price Mid Cp Gr Instl
POIRX15.76N/A
N/A
Polen International Growth Investor
HEMCX8.88-0.03
-0.34%
Janus Henderson Emerging Markets C

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with MGTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
+0.19%
MGTX - ANNX
44%
Loosely correlated
+1.72%
DNTH - ANNX
40%
Loosely correlated
-2.41%
FULC - ANNX
40%
Loosely correlated
-0.67%
FDMT - ANNX
40%
Loosely correlated
-4.99%
INZY - ANNX
39%
Loosely correlated
-3.58%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-3.58%
BEAM - INZY
56%
Loosely correlated
-3.72%
FATE - INZY
49%
Loosely correlated
-6.76%
ABOS - INZY
49%
Loosely correlated
-2.53%
DNLI - INZY
49%
Loosely correlated
-0.82%
PGEN - INZY
48%
Loosely correlated
+7.91%
More